Skip to content

A Randomized Controlled Trial of Dose Effect of Tacrolimus Ointment on Exfoliative Cheilitis

A Randomized Controlled Trial of Dose Effect of Tacrolimus Ointment on Exfoliative Cheilitis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015373
Enrollment
Unknown
Registered
2018-03-27
Start date
2017-11-01
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exfoliative cheilitis

Interventions

A:Use once a day 0.1% tacrolimus ointment + Use 2 times daily physiological saline wet compress
B:Use once every other day 0.1% tacrolimus ointment + Use 2 times daily physiological saline wet compress

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Meet diagnostic criteria for exfoliative cheilitis (Liu Furen, Practical Dermatology, Third Edition, Beijing, People's Medical Publishing House, 2005, 914-915); aged 18-60 years old; tacrolimus ointment or glucocorticoids are not used within 1 month ; subjects had no other oral mucosal diseases; the subjects informe consent and consente to treatment.

Exclusion criteria

Exclusion criteria: Pregnancy and lactation women; Patients with systemic or mental illness; Patients who do not respond to treatment or do not take medication as required

Design outcomes

Primary

MeasureTime frame
Desquamation area;

Secondary

MeasureTime frame
Dry cracking;Desquamation;Itching and pain;visual analogue scale;

Countries

China

Contacts

Public ContactWei-Wen Jiang

Department of Oral Mucosal Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

wwjiang33@hotmail.com+86 18930571293

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026